联合作者(
Pritha Ray Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Asmita Sakpal Imaging Cell Signalling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Snehal M. Gaikwad National Cancer Institute, NIH Bethesda, Washington DC
1 protocol

Priti S. Shenoy Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Sourav Chakraborty
  • Ph. D. Candidate, Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
  • 已发表 protocol 1
已发表 protocol 1篇
Developing Clinically Relevant Acquired Chemoresistance Models in Epithelial Ovarian Cancer Cell Lines
上皮性卵巢癌细胞临床相关获得性化疗耐药模型的建立

作者:Priti S. Shenoy, Sourav Chakraborty, Snehal M. Gaikwad, Asmita Sakpal and Pritha Ray日期:02/05/2022,浏览量:2072,Q&A: 0

Chemoresistance, the ability of cancer cells to overcome therapeutic interventions, is an area of active research. Studies on intrinsic and acquired chemoresistance have partly succeeded in elucidating some of the molecular mechanisms in this

...